Elizabeth Potente

Elizabeth Potente has a diverse work experience in the healthcare industry spanning over several years. Elizabeth is currently working as the Director of Health Systems and Outcomes at Intercept Pharmaceuticals, starting in 2023. Prior to this, they served as the Senior Director of Health Systems Medical Affairs at Epizyme from July 2022 to March 2023.

From July 2021 to July 2022, Elizabeth worked as the Director of Health Economics and Outcomes Research at Exact Sciences, where they provided HEOR support for the Western US region. Before that, they were a Health Economic and Value Specialist at Chiesi USA, Inc. from July 2018 to June 2021, where they supported the Cardiovascular portfolio and facilitated positive positioning on formulary adoption.

Furthermore, Elizabeth held the position of Associate Director of HEOR and Patient Access at Baxter Healthcare Corporation from December 2015 to March 2018. Elizabeth also worked as a Medical Science Liaison in Health Economics and Outcomes Research at Avanir Pharmaceuticals from February 2014 to November 2015.

Prior to that, Elizabeth served as the Associate Director of Health Outcomes and Market Access at EMD Serono, Inc. from October 2012 to January 2014. During this time, they provided clinical and health outcomes support to key managed markets customers and collaborated with external customers and academics for the development of health outcomes educational programs.

Elizabeth's earlier work experience includes roles such as Senior Liaison in Health Economics and Outcomes Research at Centocor Ortho Biotech, Johnson and Johnson, from August 1999 to March 2010, and Manager of Clinical Affairs Outcomes at Ortho Biotech from 1999 to 2005.

Elizabeth began their career as a Clinical Program Manager at MedImpact from 1997 to 1999. Throughout their career, Elizabeth has demonstrated their expertise in health systems and outcomes, health economics, market access, and clinical affairs.

Elizabeth Potente attended the University of Southern California from 1988 to 1994, where they obtained a PharmD degree in Pharmacy. In 2019, they briefly studied Population Health Certification at Thomas Jefferson University. In the previous year, they pursued a Lean Health Certification at the University of Michigan. No further information is provided about their education history before attending the University of Southern California.